Appointments

With his 20 years of expertise and proven track record in biotech and pharmaceutical industries, Curve Therapeutics appoints Simon Jones as chief financial officer (CFO) and chief operating officer (COO).

Simon Kerry, chief executive officer of Curve Therapeutics, commented on the appointment: “Simon brings extensive financial experience at the leadership level from multiple clinical stage biotech companies. His appointment comes at a pivotal time as we look to expand our team, advance our proprietar y Microcycle discovery platform and progress our pipeline of potential first-inclass assets.”

Simon’s extensive experience spans leading the financial operations at Karus, which gained the company significant international funding and spearheading the Finance and Operations units at SpyBiotech, which led to vaccine success, as well as having held significant operational and commercial positions. This vast experience is sure to strengthen Curve's leadership team following a £40.5m Series A investment.

With Simon’s assistance, Curve Therapeutics strives to save lives and enable the treatment of difficult disease targets through its development of direct screening technology.

Speaking on his new role, Simon Jones reports: “Curve’s revolutionary Microcycle discovery platform and rich pipeline of assets means that it is a company primed to disrupt the drug discovery space. I am excited to be joining as the Company expands and transitions to become a clinical stage company.”